drugset / Trial / NCT00265616

Treatment of Refractory Status Epilepticus

NCT00265616

Phase 3 Terminated 23 enrolled Brigham and Women's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether propofol or barbiturates should be preferred in the treatment of status epilepticus (continuous seizure activity) refractory to 2 standard antiepileptic agents.

Timeline

Start
2006-05
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentobarbital Small molecule 2 mg/kg Other
Comparator Propofol Small molecule 2 mg/kg Other
Comparator Thiopental Small molecule 2 mg/kg Other

Indications

No indication recorded.